Sort
82,697 grants matching “vaccine development”
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$718,581Amy Kristine Bei · Yale University · R01 · FY2023 · AI
Visceral Leishmanasis in Bihar State, Indian
$718,575Shyam Sundar · Banaras Hindu University · P50 · FY2009 · AI
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$718,534Ofer Levy · Boston Children'S Hospital · U19 · FY2017 · AI
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$718,514Anne Moscona · Columbia University Health Sciences · R01 · FY2017 · AI
Vaccines to Induce Functional Antibodies Targeting the V2 Loop
$718,447Susan B Zolla-Pazner · New York University School Of Medicine · P01 · FY2013 · AI
Multivalent mRNA-based malaria vaccines
$718,445James Matthew Burns · Drexel University · R01 · FY2025 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$718,413David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study)
$718,403Anna R Giuliano · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Durable Vaginal Protection from HIV via mRNA expression of BNABS
$718,310Philip J Santangelo · Emory University · R01 · FY2021 · AI
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE
$718,307University Of New Mexico · U19 · FY2001 · AI
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs
$718,306James L Riley · University Of Pennsylvania · R01 · FY2024 · AI
Novel Recombinant Streptococcus mitis as an Oral Vaccine against HIV/AIDS
$718,151Mark Cayabyab · Nova Southeastern University · R01 · FY2021 · DE
Harnessing oral mucosa vaccination to drive protective HIV antibody responses
$718,084Donald L Sodora · Seattle Children'S Hospital · R01 · FY2020 · DE
Systems-level identification of key regulators deciding immune cell state
$718,083Wei Wang · University Of California, San Diego · R01 · FY2020 · AI
Developing capsid-importin alpha inhibitors for the treatment of VEEV infection
$718,061Mikell Paige · George Mason University · R01 · FY2021 · AI
Developing a Multi-epitope Pan-Coronavirus Vaccine
$717,976Lbachir Benmohamed · University Of California-Irvine · R01 · FY2021 · AI
HIV-Receptor Interactions and Related Anti-HIV Strategies
$717,965Edward Berger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$717,895Jay B Jackson · Johns Hopkins University · U01 · FY2006 · AI
US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)
$717,894Juliet Iwelunmor · Washington University · U54 · FY2025 · CA
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2014 · AI
Molecular Pharmacology of NKT Cell Agonists
$717,836Luc Teyton · Scripps Research Institute, The · R01 · FY2015 · AI
Next generation mosquito control through technology-driven trap development and artificial intelligence guided detection of mosquito breeding habitats
$717,814Melissa Suzanne Nolan · University Of South Carolina At Columbia · R01 · FY2025 · AI
IMPROVEMENT OF THE COTTON RAT MODEL OF HUMAN DISEASES
$717,767Virion Systems, Inc. · R24 · FY2001 · RR
Improving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient Portal
$717,747Peter G Szilagyi · University Of California Los Angeles · R01 · FY2019 · AI
New Approaches To Passive Immunoprophylaxis
$717,699Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI